Viewing Study NCT02243202


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-28 @ 3:31 AM
Study NCT ID: NCT02243202
Status: COMPLETED
Last Update Posted: 2016-10-06
First Post: 2014-09-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Obesity View
None Overweight View
None Canagliflozin View
None Phentermine View
None INVOKANA® View